Welcome to our dedicated page for Linkage Global news (Ticker: UZX), a resource for investors and traders seeking the latest updates and insights on Linkage Global stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Linkage Global's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Linkage Global's position in the market.
Linkage Global (Nasdaq: UZX) received a Nasdaq notice on June 3, 2026 that its Class A shares no longer meet the $1 minimum bid price requirement under Rule 5550(a)(2) after 30 consecutive business days below that level.
The notice does not immediately affect listing or trading, and UZX will continue on Nasdaq. Linkage Global has a 180-day compliance period until November 30, 2026, with a possible additional 180 days if certain criteria are met. The company is evaluating options, including a potential reverse stock split, but warns there is no assurance it will regain compliance or satisfy all continued listing requirements.
Linkage Global (NASDAQ: UZX) authorized a $8 million share repurchase program for its Class A ordinary shares. The move follows a recent corporate rebranding and Nasdaq ticker change to UZX and is planned to be funded with existing cash and future cash flow.
Repurchases may occur via open market, private deals, block trades or other permitted methods, with timing and size determined by capital position, liquidity, performance and market conditions. The program is discretionary and can be modified, suspended or discontinued.